RiverPark Advisors’s Biote Corp BTMD Stock Holding History

RiverPark Advisors’s Portfolio BTMD Stock Details BTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-135,273	Closed	-$837K	–	50
2023 Q1	$837K	Buy	135,273 +94,188	+229%	+$422K	0.56%	52
2022 Q4	$153K	Sell	41,085 -40,206	-49%	-$168K	0.07%	91
2022 Q3	$348K	Buy	+81,291	New	+$345K	0.11%	112
2022 Q2	–	Sell	-100,000	Closed	-$988K	–	142
2022 Q1	$988K	Hold	100,000	–	–	0.18%	90
2021 Q4	$983K	Buy	+100,000	New	+$977K	0.12%	103

Other funds holding BTMD

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VCM

Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

RiverPark Advisors's BTMD Position: Q2 2023 in Review

RiverPark Advisors sold out of Biote Corp (BTMD) in Q2 2023, closing a stake of 135,273 shares — an estimated $837K sold.

RiverPark Advisors first reported a position in BTMD in Q4 2021 and held it in 5 quarters. The position peaked at $988K in Q1 2022. 55 funds tracked by Wall St. Rank hold BTMD as of Q2 2023.

RiverPark Advisors reported no remaining Biote Corp position as of Q2 2023 after selling out during the quarter.
RiverPark Advisors sold 135,273 Biote Corp shares in Q2 2023, an estimated $837K.
RiverPark Advisors first reported a position in Biote Corp in Q4 2021 and held it in 5 quarters.
RiverPark Advisors's Biote Corp position peaked at $988K in Q1 2022.
55 funds tracked by Wall St. Rank held Biote Corp as of Q2 2023.

Based on RiverPark Advisors's 13F filing for Q2 2023, filed 27 Jul 2023.